Wheeler Real Estate Investment Trust, Inc. engages in the acquisition, finance, development, lease, ownership, and management of retail properties. Its property portfolio includes income producing, strip centers, neighborhood, grocery-anchored, community, and free-standing retail properties. The company was founded on June 23, 2011 and is headquartered in Virginia Beach, VA.

Creative Media & Community Trust Corp. is a real estate investment trust that seeks to own, operate, and develop premier multifamily and creative office assets in vibrant and emerging communities throughout the United States. It operates through the following segments: Office, Hotel, and Lending. The Office segment consists of the rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The Hotel segment involves the operation of hotel properties. The Lending segment focuses on loans to small businesses. The company was founded in 1993 and is headquartered in Dallas, TX.

N2OFF, Inc. operates as an agri-food tech company. It specializes in eco crop protection that helps to reduce food waste and ensure food safety while reducing the use of pesticides. The firm's geographical segments include United States, Mexico, Israel and Turkey. Its products include SpuDefender and FreshProtect. The SpuDefender is designed to control the post-harvest potato sprout. The FreshProtect is designed to control spoilage-creating microorganisms on post-harvest citrus fruit. The company was founded by Nimrod Ben-Yehuda on April 1, 2009 and is headquartered in Neve Yarak, Israel.

SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It is engaged in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Sioux Falls, SD.

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.

Xiao-I Corp. operates as a holding company, which through its subsidiaries primarily engages in Internet technology development. The company was founded in 2001 and is headquartered in Shanghai, China.

Heritage Global, Inc. engages in the provision of corporate and financial asset liquidation transactions, valuations, and advisory services. It operates through the following segments: Auction and Liquidation, Refurbishment and Resale segment, Brokerage, and Specialty Lending. The Auction and Liquidation segment focuses on the operation of a global full-service auction, appraisal and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment. The Refurbishment and Resale segment acquires, refurbishes and supplies specialized laboratory equipment. The Brokerage segment is involved in charged-off receivables in the U.S. and Canada on behalf of financial institutions. The Specialty Lending segment provides specialty financing solutions to investors in charged-off and nonperforming asset portfolios. The company was founded in 1983 and is headquartered in San Diego, CA.

Nuburu, Inc. focuses on bringing breakthrough improvements to a broad range of high value applications including welding and 3D printing. Its products, NUBURU AO and NUBURU BL series lasers, weld copper, aluminum, and dissimilar metals faster and better than any alternative approach. The company was founded by Mark S. Zediker and Jean-Michel Pelaprat in 2015 and is headquartered in Centennial, CO.

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Petros Pharmaceuticals, Inc. engages in men's health therapeutics. It is involved in sales, marketing, regulatory and medical affairs, finance, trade relations, pharmacovigilance, market access relations, manufacturing, and distribution. It operates through the Prescription Medications and Medical Devices segments. The Prescription Medications segment handles Stendra, a FDA approved PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction, and H100, a topical formulation candidate for the treatment of acute Peyronie's disease. The Medical Devices segment consists of vacuum erection devices. The company was founded on May 14, 2020 and is headquartered in New York, NY.